Performance of somatic structural variant calling in lung cancer using Oxford Nanopore sequencing technology
Abstract Background Lung cancer is a heterogeneous disease and the primary cause of cancer-related mortality worldwide. Somatic mutations, including large structural variants, are important biomarkers in lung cancer for selecting targeted therapy. Genomic studies in lung cancer have been conducted u...
Guardat en:
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2024-09-01
|
| Col·lecció: | BMC Genomics |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s12864-024-10792-3 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
